1. Home
  2. LNG vs NNVC Comparison

LNG vs NNVC Comparison

Compare LNG & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheniere Energy Inc.

LNG

Cheniere Energy Inc.

N/A

Current Price

$272.03

Market Cap

55.5B

Sector

Utilities

ML Signal

N/A

NNVC

NanoViricides Inc.

N/A

Current Price

$1.28

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LNG
NNVC
Founded
1983
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.5B
35.2M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
LNG
NNVC
Price
$272.03
$1.28
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
22
2
Target Price
★ $310.19
$6.00
AVG Volume (30 Days)
★ 1.9M
601.5K
Earning Date
11-05-2026
09-28-2026
Dividend Yield
★ 0.83%
N/A
EPS Growth
★ 69.93
34.92
EPS
N/A
★ N/A
Revenue
★ $19,976,000,000.00
N/A
Revenue This Year
$17.13
N/A
Revenue Next Year
$2.77
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 27.21
N/A
52 Week Low
$186.20
$0.85
52 Week High
$300.94
$2.23

Technical Indicators

Market Signals
Indicator
LNG
NNVC
Relative Strength Index (RSI) 44.82 46.97
Support Level $264.36 $1.21
Resistance Level $277.78 $1.38
Average True Range (ATR) 6.33 0.15
MACD -1.07 0.00
Stochastic Oscillator 23.86 36.31

Price Performance

Historical Comparison
LNG
NNVC

About LNG Cheniere Energy Inc.

Cheniere Energy is a liquefied natural gas producer with two facilities in Corpus Christi, Texas, and Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. A subsidiary, Cheniere Energy Partners, owns the Sabine Pass facility and trades as a master limited partnership.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: